Expecting
3 min Read
Prenatal Genetic Testing

March 15, 2011
Expecting
3 min Read
March 15, 2011
Today all pregnant women can be tested to determine their risk of having a baby with a chromosome abnormality.
Sometimes the normal orderly sorting goes wrong and produces an abnormality of development. There is no way to prevent this but there are two types of available testing to find an abnormality: Screening and Diagnostic.
Prenatal Genetic Screening Tests
Screening tests indicate the chance of disease and assists a pregnant woman in deciding whether or not to have an invasive diagnostic testing.
Down Syndrome
The usual cause of Down Syndrome is to have an extra copy of chromosome number 21. We don’t know what causes the abnormality of chromosome sorting but this occurs with increasing age of the mother.
Nuchal Translucency
This test measures the fluid under the skin at the back of the neck of the fetus between 11 and 14 weeks. Fetuses with Down Syndrome tend to have an increased amount of fluid, indicating increased risk.
Serum Screen, “Triple Screen” or “Quad Screen”
This is a test for certain chemicals made by the fetus that appear in the blood of the mother in somewhat different amounts than normal when the fetus has Down Syndrome. It is performed at about 15-20 weeks.
Eighteen Weeks Structural Ultrasound
This test is routinely offered in Canada. Benefits include being able to look for structural abnormalities. There are “markers” for Down Syndrome, which may also be present in normal fetus. These abnormalities or markers are seen in at least half the fetuses with Down Syndrome.
When combined with the nuchal translucency and a serum screen at about 15 weeks about 90 percent of cases of Down Syndrome can be identified.
Amniocentesis
This is the most common test, usually done at about 16 weeks. Cells from the fetus are recovered by putting a needle through the abdominal wall into the fluid surrounding the fetus and the chromosomes get counted. It takes two to three weeks to get an answer. This is the definitive diagnostic test that can rule in or out the presence of an abnormal number of chromosomes. The risk with amniocentesis is a one in 200 chance of loss of the pregnancy.
There are two important limitations:
CVS
Chorionic villous sampling is less readily available and samples tissue from the placenta. A tube or biopsy forcep is placed through the cervix or a needle is placed through the abdominal wall into the placenta, to remove a portion of placental tissue. This test can be done at around 11-12 weeks.
The risk of pregnancy loss due to CVS testing is a little bit higher than amniocentesis, but the benefit is a definite diagnosis at an earlier gestational age.